(Q41384817)

English

Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells

scientific article published on 27 April 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

systems biology

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

5

object named as

A D M E Osterhaus

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

6

object named as

Suzan D Pas

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

4

object named as

Arno C Andeweg

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

author name string

Thomas Vanwolleghem

1

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Jun Hou

2

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Gertine van Oord

3

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Harry L A Janssen

7

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

language of work or name

0 references

publication date

27 April 2015

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

62

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

87-100

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Dynamics of hepatitis B virus clearance in chimpanzees

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Experimental models for hepatitis C viral infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Innate response to hepatitis B virus infection: Observations challenging the concept of a stealth virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Common patterns and disease-related signatures in tuberculosis and sarcoidosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Gene expression profiling to predict and assess the consequences of therapy-induced virus eradication in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Significance analysis of microarrays applied to the ionizing radiation response

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Statistical significance for genomewide studies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

The 'miss rate' for the analysis of gene expression data

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Microarray and gene ontology analyses reveal downregulation of DNA repair and apoptotic pathways in diethylstilbestrol-exposed testicular Leydig cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Cumulative viral evolutionary changes in chronic hepatitis B virus infection precedes hepatitis B e antigen seroconversion

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Distinct hepatitis B virus dynamics in the immunotolerant and early immunoclearance phases.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunity.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Immunosuppression and HBV reactivation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Genomic analysis of the host response to hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Control of hepatitis B virus replication by innate response of HepaRG cells.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Serum levels of interferon-gamma-inducible protein 10 and response to peginterferon therapy in HBeAg-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

21 January 2018

Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

7 January 2021

based on heuristic

inferred from DOI database lookup

Reasons to consider earlier treatment of chronic HBV infections

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27805

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.27805

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41384817&oldid=2221388673"